MENU
JUN 10, 2016 8:00 AM PDT

Lupus Anticoagulant (LA): Choosing the Right Testing Strategy for Your Laboratory

Sponsored by: Diagnostica Stago, Inc.
Speaker
  • Associate Professor of Pathology at the Cedars Sinai Medical Center (CSMC) and University of California Los Angeles Hospital
    Biography
      Oksana Volod, MD is Associate Professor of Pathology at the Cedars Sinai Medical Center (CSMC) and University of California Los Angeles Hospital in Los Angeles, CA. She is responsible for the coagulation laboratory and works extensively across multiple departments to ensure best patient testing practices. Her clinical research interests include viscoelastic test utilization for personalized treatment of complex coagulopathies and development of optimal anticoagulation strategies for patients on mechanical circulatory support devices (MCS). In addition, she is a member of the Coagulation Resource Committee of the College of American Pathologists (CAP). Prior to her current position, she performed her residency in Anatomic and Clinical Pathology, along with a fellowship in hematopathology and coagulation at CSMC. She was also a visiting fellow in coagulation at the Royal Free Hospital in London, UK and previously earned her MD at the Uzhgorod State University in Ukraine.

    Abstract

    Lupus anticoagulants are markers of prothrombotic potential which may be indicative of underlying antiphospholipid syndrome (aPS) requiring treatment with ongoing anticoagulants.  The purpose of this educational program is to update healthcare professionals regarding advancements in Lupus Anticoagulant (LA) testing. Current LA diagnostic guidelines, clinical evidence regarding LA significance, assay selection, and anticoagulant drugs interfering with LA testing will be discussed, along with clinical cases of high interest.

    • Describe role of Lupus Anticoagulant (LA) in Antiphospholipid Syndrome (APS).
    • Define current ISTH and CLSI Guidelines, identify tests, and define patient selection for appropriate LA work up.
    • Recognize medications that may cause false positive LA results.
    • Evaluate the right testing strategy for LA testing.
    • Correlate LA and APS to specific clinical cases.

    Show Resources
    You May Also Like
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    APR 07, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    MAY 12, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 12, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: May 12, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    Loading Comments...
    Show Resources